Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Circulating extracellular vesicle associated-microRNAs as predictive biomarkers of cardiac arrest in patients with end-stage renal disease

FY 2016-17

Summary
An estimated three million Canadians have or are at risk of having chronic kidney disease. End-stage renal disease (ESRD), the last stage of chronic kidney disease, is a serious life threatening condition in which the kidneys do not work well enough for survival without treatment. Cardiovascular complications are the leading cause of death in ESRD patients, with cardiac arrest accounting for roughly a quarter of all deaths. Cardiovascular changes in ESRD and pathological inflammation may predispose these patients to cardiac arrest. So far, we have failed to identify early indicators for cardiac arrest in this patient population, making intervention nearly impossible. Recently extracellular vesicles, small particles that circulate in the blood, and their cargo have been explored as predictors for disease. In particular, their cargo molecules, known as miRNA, are altered by disease processes occurring in the body and have great potential for being used as markers that predict disease progression and outcome. To date, the main challenge in using extracellular vesicles and their miRNA content for disease prediction has been finding large enough patient groups for accurate study. To address this challenge I will utilize our collection of 571 ESRD patient samples to identify miRNA or extracellular vesicle biomarkers that are predictive of cardiac arrest. Importantly, the clinical history of these patients is already known, and we have multiple samples collected throughout the disease progression. I expect this research will lead to the development of early warning markers for cardiac arrest that will allow us to tailor treatment for those at the highest risk. This may decrease the global health and economic burden of chronic kidney disease.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
367140
Name
Gustafson Dakota D
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Circulating extracellular vesicle associated-microRNAs as predictive biomarkers of cardiac arrest in patients with end-stage renal disease
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Biomarkers; Cardiac Arrest; Chronic Kidney Disease; Extracellular Vesicle; Mirna; Plasma; Renal
Abstract
An estimated three million Canadians have or are at risk of having chronic kidney disease. End-stage renal disease (ESRD), the last stage of chronic kidney disease, is a serious life threatening condition in which the kidneys do not work well enough for survival without treatment. Cardiovascular complications are the leading cause of death in ESRD patients, with cardiac arrest accounting for roughly a quarter of all deaths. Cardiovascular changes in ESRD and pathological inflammation may predispose these patients to cardiac arrest. So far, we have failed to identify early indicators for cardiac arrest in this patient population, making intervention nearly impossible. Recently extracellular vesicles, small particles that circulate in the blood, and their cargo have been explored as predictors for disease. In particular, their cargo molecules, known as miRNA, are altered by disease processes occurring in the body and have great potential for being used as markers that predict disease progression and outcome. To date, the main challenge in using extracellular vesicles and their miRNA content for disease prediction has been finding large enough patient groups for accurate study. To address this challenge I will utilize our collection of 571 ESRD patient samples to identify miRNA or extracellular vesicle biomarkers that are predictive of cardiac arrest. Importantly, the clinical history of these patients is already known, and we have multiple samples collected throughout the disease progression. I expect this research will lead to the development of early warning markers for cardiac arrest that will allow us to tailor treatment for those at the highest risk. This may decrease the global health and economic burden of chronic kidney disease.
Competitiondate
201612
Approvedterm2
1 yr 0 mth
Pinamesdelim
Gustafson, Dakota D
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~